THE EFFECTS OF NITROGLYCERIN ON THE PROLIFERATIVE AND MIGRATORY POTENTIAL OF PERIPHERAL BLOOD MONONUCLEAR CELLS

Aim. To study the effects of nitroglycerin on proliferative and migratory activity of mononuclear cells and endothelial progenitor cells in patients with chronic heart failure.

Materials and methods. Proliferative potential of peripheral blood mononuclear cells in donors and patients were studied in MTT-test in the presence of 50 and 100 mg/ml nitroglycerin. Proliferation and migration of endothelial progenitor cells in patients were evaluated by changes in the cell impedance in real-time in the presence of various doses of nitroglycerin.

Results. It is shown that nitroglycerin reduces in vitro both spontaneous and Concanavalin A stimulated proliferative activity of mononuclear cells in patients with chronic heart failure. Peripheral blood mononuclear cells in patients with chronic heart failure, obtained after procedure of mobilization by granulocyte colony-stimulating factor respond to nitroglycerin dose of 50 mg/ml with the increased proliferative activity, and with the suppressed proliferative activity to nitroglycerin dose of 100 mg/ml. Mononuclear cells of healthy donors respond to 50 mg/ml of nitroglycerin with the activation of proliferative capacity, but at a dose of 100 mg/ml spontaneous proliferative activity of mononuclear cells inhibit. It is also shown that the presence of nitroglycerin in medium dose in stimulating test leads to the inhibition of mononuclear cells proliferation from healthy donors. It is shown the stimulating effect of nitroglycerin on proliferative and migration potential of endothelial progenitor cells.

Conclusion. Multidirectional and dose-dependent effects of nitroglycerin to the various types of human cells in vitro were observed.

1. Meunzel T. Does nitroglycerin therapy hit the endothelium? Journal of the American College of Cardiology. 2001; 38: 1102–1105.

2. Mayer B, Beretta M. The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. Br. J. Pharmacol. 2008; 155: 170–184.

3. Gori T, Parker JD. Nitrate tolerance: a unifying hypothesis. Circulation. 2002; 106: 2510–2513.

4. Munzel T, Daiber A, Gori T. Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance. Circulation. 2011; 123: 2132–2144.

5. DiFabio JM, Thomas GR, Zucco L et al. Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J. Pharmacol. Exp. Ther. 2006; 318: 117–123.

6. Huang L, Qiu N, Zhang C et al. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway. Acta. Pharmacol. Sin. 2008; 29: 580–586.

7. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005; 45: 321–325.

8. Лыков АП, Повещенко ОВ, Бондаренко НА, Повещенко АФ, Ким ИИ, Миллер ТВ и др. Оценка эффекта проангиогенных факторов на пролиферативную и миграционную активность клеток эндотелиальной линии EA.Hy926. Бюллетень СО РАМН. 2013;4: 23–29. Lykov AP, Poveshhenko OV, Bondarenko NA, Poveshhenko AF, Kim II, Miller TV et al. Estimation of the effect of proangiogenic factors on the proliferative and migration activities of the endothelial cells of line EA.Hy926. Bjulleten' SO RAMN. 2013; 4: 23–29.

9. Kaesemeyer W, Ogonowski A, Jin L et al. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br. J. Pharmacol. 2000; 131: 1019–1023.

10. Roland CR, Mangino MJ, Flye MW. Lanthanide «blockade » of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 1993; 54: 401–410.

11. Bamberger Т, Masson I, Mathieu J et al. Nitric oxide mediates the depression of lymphoproliferative responses following burn injury in rats. Biomed. Pharmacother. 1992; 46: 495–500.

12. Ким ИИ, Повещенко ОВ, Коненков ВИ, Покушалов ЕА, Романов АБ, Бондаренко НА и др. Эффективность мобилизации CD34+ прогениторных клеток препаратом G-CSF в зависимости от ишемического анамнеза и возраста больных с хронической сердечной недостаточностью. Патология кровообращения и кардиохирургия. 2012; 1: 75–78. Kim II, Poveshhenko OV, Konenkov VI, Pokushalov EA, Romanov AB, Bondarenko NA et al. Effi cacy of the mobilization of CD34 + progenitor cells by G-CSF administrations depends at the ischemic anamnesis and age of patients with chronic heart failure. Patologija krovoobrashhenija i kardiohirurgija. 2012; 1: 75–78.

13. Cтарикова ЭА, Амчиславский ЕИ, Соколов ДИ, Фрейдлин ИС, Полосухина ЕР, Барышников Ю. Изменение поверхностного фенотипа эндотелиальных клеток под влиянием ровоспалительных и противовоспалительных цитокинов. Медицинская иммунология. 2003; 1–2: 39–48. Ctarikova JeA, Amchislavskij EI, Sokolov DI, Frejdlin IS, Polosuhina ER, Baryshnikov AJu. Deviations of endothelial cells surface phenotype under the infl uence of pro-infl ammatory and anti-infl ammatory cytokines. Medicinskaja immunologija. 2003; 1–2: 39–48.

14. Бондаренко НА. Морфофункциональная характеристика эндотелиальных прогениторных клеток при хронической сердечной недостаточности: дис. … канд. биол. наук. Н., 2013: 17. Bondarenko NA. Morphofunctional characterization of endothelial progenitor cells in patients with chronic heart failure: dis. … kand. biol. nauk. N., 2013: 17.